Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder
Conditions:   Sjogren's Syndrome;   Overactive Bladder Syndrome Interventions:   Drug: mirabegron;   Drug: oxybutynin, tolterodine, solifenacin Sponsor:   China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials

Olfactory and Taste Disturbances in Sjogren's Syndrome
Condition:   Sjogren's Syndrome Interventions:   Other: Evaluation of olfactory function;   Other: Evaluation of taste function;   Other: Evaluation of (intra-nasal and oral) trigeminal functions Sponsor:   Université de Reims Champagne-Ardenne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials

Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder
Conditions:   Sjogren's Syndrome;   Overactive Bladder Syndrome Interventions:   Drug: mirabegron;   Drug: oxybutynin, tolterodine, solifenacin Sponsor:   China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials

Olfactory and Taste Disturbances in Sjogren's Syndrome
Condition:   Sjogren's Syndrome Interventions:   Other: Evaluation of olfactory function;   Other: Evaluation of taste function;   Other: Evaluation of (intra-nasal and oral) trigeminal functions Sponsor:   Université de Reims Champagne-Ardenne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials

Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder
Conditions:   Sjogren's Syndrome;   Overactive Bladder Syndrome Interventions:   Drug: mirabegron;   Drug: oxybutynin, tolterodine, solifenacin Sponsor:   China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2021 Category: Research Source Type: clinical trials

Olfactory and Taste Disturbances in Sjogren's Syndrome
Condition:   Sjogren's Syndrome Interventions:   Other: Evaluation of olfactory function;   Other: Evaluation of taste function;   Other: Evaluation of (intra-nasal and oral) trigeminal functions Sponsor:   Université de Reims Champagne-Ardenne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2021 Category: Research Source Type: clinical trials

Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder
Conditions:   Sjogren's Syndrome;   Overactive Bladder Syndrome Interventions:   Drug: mirabegron;   Drug: oxybutynin, tolterodine, solifenacin Sponsor:   China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2021 Category: Research Source Type: clinical trials

Olfactory and Taste Disturbances in Sjogren's Syndrome
Condition:   Sjogren's Syndrome Interventions:   Other: Evaluation of olfactory function;   Other: Evaluation of taste function;   Other: Evaluation of (intra-nasal and oral) trigeminal functions Sponsor:   Université de Reims Champagne-Ardenne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2021 Category: Research Source Type: clinical trials

CEQUA for Sjogren's Syndrome Dry Eye
Conditions:   Dry Eye;   Dry Eye Syndromes;   Sjogren's Syndrome Intervention:   Drug: Cyclosporine 0.09% Ophthalmic Solution Sponsors:   Center for Ophthalmic and Vision Research, LLC;   Sun Pharma Global FZE Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2021 Category: Research Source Type: clinical trials